Communiqués Evogene Ltd. Nasdaq

Actions

EVGN

IL0011050551

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 02/10/2026			Varia. 5j.	Varia. 1 janv.
0,4250 ^USD	-2,43%		+2,24%	-61,36%

15/09	Evogene Ltd. annonce des changements au sein de son conseil d'administration	CI
11/09	L.I.A. Pure Capital a l'intention de lancer une offre publique d'achat simplifiée sur Evogene	CI

Communiqués

30/09	Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance	PR
31/08	Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward	PR
25/08	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees	PR
18/08	Evogene Reports Second Quarter and First Half 2026 Financial Results	PR
18/08	Evogene : Reports Second Quarter and First Half 2026 Financial Results	PU
18/08	Evogene: Q2 Earnings Snapshot	AQ
17/08	Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation	AQ
14/08	Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation	PR
30/07	Evogene Schedules Second Quarter 2026 Financial Results Release	PR
22/07	Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases	PR
08/07	Evogene : and Tel Aviv University’s Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery	PU
02/06	Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica	PR
20/05	Evogene : Q1 2026 Consolidated Financial Statements	PU
20/05	Evogene: Q1 Earnings Snapshot	AQ
20/05	Evogene Reports First Quarter 2026 Financial Results	PR
12/05	Evogene to Present at the 24th Schrödinger European User Group Meeting	PR
07/05	Evogene Schedules First Quarter 2026 Financial Results Release	PR
02/04	Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification	PR
31/03	Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock	PR
05/03	Evogene : Q4 and Full Year 2025 Consolidated Financial Statements	PU
05/03	Evogene: Q4 Earnings Snapshot	AQ
05/03	Evogene Reports Fourth Quarter and Full Year 2025 Financial Results	PR
25/02	Evogene Releases CEO Letter to Shareholders	PR
17/02	Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics	PR
11/02	Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases	PR